Literature DB >> 10036303

Down regulation of the prepro-orexin gene expression in genetically obese mice.

Y Yamamoto1, Y Ueta, Y Date, M Nakazato, Y Hara, R Serino, M Nomura, I Shibuya, S Matsukura, H Yamashita.   

Abstract

The gene expression of prepro-orexin, the precursor of orexin-A and orexin-B which are hypothalamic pepetides that are associated with feeding behavior, were examined in control (C57B1/6J) and obese (ob/ob and db/db) mice using in situ hybridization histochemistry. Orexins are identical with hypocretins that have been identified by directional tag PCR subtractive hybridization method. In situ hybridization histochemistry revealed that the expression of the prepro-orexin gene was significantly decreased in ob/ob and db/db mice compared with control mice. The gene expression of neuropeptide Y (NPY), a potent feeding stimulant, is known to be increased in ob/ob and db/db mice. The expression of the NPY gene in the arcuate nucleus was increased remarkably in ob/ob and db/db mice compared to that of control mice. An immunohistochemical study showed that orexin-A and orexin-B immunoreactive neurons exhibited in the lateral and posterior hypothalamic areas and the perifornical nucleus were distributed similarly in control, ob/ob and db/db mice. These results suggest that the regulatory mechanism of orexins/hypocretins may be different from that of NPY in genetically obese mice. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10036303     DOI: 10.1016/s0169-328x(98)00320-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  21 in total

Review 1.  Hypocretins in the control of sleep and wakefulness.

Authors:  Patricia Bonnavion; Luis de Lecea
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 2.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

Review 3.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

4.  Orexin A regulates plasma insulin and leptin levels in a time-dependent manner following a glucose load in mice.

Authors:  Jae-Hyung Park; Hae-Min Shim; Ann-Yae Na; Jae-Hoon Bae; Seung-Soon Im; Dae-Kyu Song
Journal:  Diabetologia       Date:  2015-03-28       Impact factor: 10.122

5.  Gastrointestinal-projecting neurones in the dorsal motor nucleus of the vagus exhibit direct and viscerotopically organized sensitivity to orexin.

Authors:  Gintautas Grabauskas; Hylan C Moises
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

6.  Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.

Authors:  Ravid Sasson; Robert K Dearth; Rachel S White; Patrick E Chappell; Pamela L Mellon
Journal:  Neuroendocrinology       Date:  2006-12-28       Impact factor: 4.914

7.  Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro.

Authors:  L L Hwang; C T Chen; N J Dun
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

Review 8.  Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

Authors:  Raphaëlle Winsky-Sommerer; Benjamin Boutrel; Luis de Lecea
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

9.  Hyperphagia and obesity produced by arcuate injection of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic peptide genes.

Authors:  Ai-Jun Li; Thu T Dinh; Sue Ritter
Journal:  Peptides       Date:  2008-06-05       Impact factor: 3.750

10.  Sleep is increased by weight gain and decreased by weight loss in mice.

Authors:  Zhiwei Guan; Alexandros N Vgontzas; Edward O Bixler; Jidong Fang
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.